Introduction:
D(+)-Galactosamine hydrochloride (CAS: 1772-03-8) is a well-established amino sugar widely used in biochemical research, pharmaceutical development, and glycobiology.
As a hydrochloride salt of D-galactosamine — a 6-carbon amino sugar derived from galactose — it serves as a critical reagent in experimental hepatology, glycoconjugate synthesis, and the study of carbohydrate-mediated biological processes.
D(+)-Galactosamine hydrochloride is a well-established experimental hepatotoxin . Its primary mechanism of action involves the depletion of intracellular uracil nucleotides, specifically UTP, which in turn inhibits hepatic RNA and protein synthesis .
This disruption leads to hepatocyte death through both necrosis and apoptosis . The compound also generates free radicals, further contributing to liver injury.
Biochemical Activity and Mechanism of Action:
Hepatotoxicity: D-Galactosamine (D-GalN) is a specific hepatotoxic agent metabolized predominantly in hepatocytes. Its toxicity stems from a well-characterized metabolic mechanism:
This mechanism produces liver injury that closely resembles human viral hepatitis, making D-GalN an invaluable tool in experimental hepatology.
Sensitization to Cytokine Toxicity:
D-GalN also sensitizes liver cells to the toxic effects of cytokines, particularly tumor necrosis factor-α (TNF-α). When combined with lipopolysaccharide (LPS), which triggers TNF-α release, D-GalN produces a synergistic, lethal hepatic injury.
This LPS/D-GalN combination is the basis of one of the most widely used models of fulminant hepatitis.
Structure–Activity Relationship:
The free amino group at C-2 is critical for hepatotoxicity. The N-acetylated analog, N-acetyl-D-galactosamine, does not induce the same hepatotoxic response, underscoring the importance of the free amine in the compound's toxicological profile.
Applications:
1. Induction of Acute Liver Injury Models
The most prominent application of D(+)-Galactosamine hydrochloride is in the establishment of LPS/D-GalN-induced acute liver failure (ALF) models in rodents .
When administered in combination with lipopolysaccharide (LPS), it leads to lethal liver injury and fulminant hepatitis, closely mimicking the pathological features of human viral hepatitis . This model is widely used for:
--Screening and evaluating potential hepatoprotective drugs
--Studying the mechanisms of hepatic inflammation and cell death
--Investigating the role of cytokines such as tumor necrosis factor (TNF) in liver injury
2. Cell Culture and Biochemical Research
D(+)-Galactosamine hydrochloride is also utilized in cell culture applications, including:
Generating primary bone marrow-derived macrophages (BMDMs) in mice; Studying the binding of mannan-binding lectin (MBL) to surfaces; And Investigating COX-2 inhibition by preventing N-glycosylation and increasing protein turnover.
3. Pharmaceutical and Glycoconjugate Synthesis
Serves as a chiral building block in the synthesis of antiviral and anti-inflammatory agents. Used in the development of glycoconjugate vaccines, where carbohydrate antigens are conjugated to carrier proteins.
Employed in the preparation of glycosides, glycopeptides, and other carbohydrate-derived therapeutics.
4. Other Research Uses
The compound serves as a biochemical reagent for:
Hepatic RNA synthesis inhibition studies; Investigating the role of polymorphonuclear leukocyte adherence to hepatic endothelial cells;And Experimental models of disseminated intravascular coagulation (DIC) combined with hepatitis.
Conclusion:
D(+)-Galactosamine hydrochloride (CAS: 1772-03-8) is a versatile and scientifically significant amino sugar whose value spans toxicology, glycobiology, pharmaceutical synthesis, and vaccine development.
Its defining characteristic — selective, mechanistically well-understood hepatotoxicity mediated through uridine nucleotide depletion — has made it an indispensable reagent for
generating reproducible preclinical models of acute liver failure and viral hepatitis-like injury.
Available in high-purity grades (≥ 99%, HPLC), including cell-culture-grade material essentially free of glucosamine, the compound meets the rigorous demands of modern biomedical research.
Product manager: Joy Wu CONTACT/Email address: Joy@coreychem.com
